Announcements Trials
Browse Landscape

Status

Completed 181Recruiting 70Terminated 52Unknown 31Active not recruiting 24Withdrawn 18Not yet recruiting 17Suspended 3Enrolling by invitation 3Approved for marketing 3Available 2No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Tumor-Agnostic 10Sarcoma 2CNS 2NET 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Neuroblastoma 6Glioblastoma 4Recurrence 3Pancreatic Neoplasms 3Head and Neck Neoplasms 3Stomach Neoplasms 2Pheochromocytoma 2Ovarian Neoplasms 2Neoplasms 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Typical Teratoid Rhabdoid Tumor 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Paraganglioma 1Neurofibromatoses 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive 1Meningioma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1

Interventions

Proton Pump Inhibitors 1Hydrocortisone 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Neoplasms × CNS × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Available
CNS

Neoplasms, Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡